Shares of drugmaker Rigel Pharmaceuticals (NASDAQ:RIGL) rose approximately 3% to $19.54 on Thursday after the company announced a settlement in its patent litigation with Annora Pharma. The dispute is ...

Hims & Hers Health (HIMS) stock enjoyed a 10% jump in price last week on news that the company plans to continue offering ...

Avoid the stress of overpaying for a stock or missing an opportunity by using the right tools and insights to evaluate Milestone Pharmaceuticals Inc. before investing. In this article, we go over a ...

Deloitte’s annual report on pharmaceutical pipeline investment put a spotlight on the market influence of GLP-1RA assets. Image credit: Shutterstock / SAG stock. The number of late-stage drug ...

Tonix Pharmaceuticals shares were up 51% at $34.67 after the company said the Food and Drug Administration will not require an advisory committee meeting to discuss a New Drug Application for TNX ...

Milestone Pharmaceuticals said on Friday the U.S. health regulator had declined to approve its nasal spray to treat a type of ...

To get a sense of who is truly in control of Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX), it is important to understand the ownership structure of the business. The group holding the most number ...

Good day and welcome to Acumen Pharma Fiscal Year 2024 Conference Call and Webcast. At this time all participants are in a listen-only mode. After the speakers’ presentation there will be a ...

Tonix Pharmaceuticals (NASDAQ:TNXP) was able to have its New Drug Application of TNX-102 SL for the treatment of patients with Fibromyalgia accepted by the FDA. Not only was this regulatory ...

The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Actinium Pharmaceuticals, Inc. (“Actinium” or “the Company”) (NYSE ...

We recently published a list of the 10 Best Mid Cap Biotech Stocks to Buy. In this article, we are going to take a look at ...